The 40th Prouty concluded this weekend with a record-breaking success of raising more than $4 million in support of cancer research and patient and family support services at Dartmouth’s and Dartmouth-Hitchcock’s Norris Cotton Cancer Center (NCCC).
Post Tagged with: "Norris Cotton Cancer Center"
Researchers at Norris Cotton Cancer Center have developed a way to predict chemotherapy response to tailor treatments for pancreatic cancer patients.
Dartmouth researchers achieve better long-term control of drug-resistant breast cancer growth in mice by switching between estrogen and anti-estrogen therapies.
Researchers at Dartmouth’s and Dartmouth-Hitchcock’s Norris Cotton Cancer Center (NCCC) have found that a certain subpopulation of cells that enters a patient’s skin and blood during immunotherapy is behind the excellent and long-lasting immune responses to cancer that some survivors develop.
Dartmouth researchers convert a standard linear accelerator used for delivery of radiation therapy cancer treatment, to deliver an ultra-high-dose rate radiation therapy beam to patients “in a flash.”
Lionel D. Lewis, MD, MA, MB BCh, has been elected as a fellow of the British Pharmacological Society, a premier global society in the science of pharmacology.
Dartmouth College alumni and health care investors have committed a total of $1.4 million in gifts to launch the Dartmouth Innovations Accelerator for Cancer which will allow for innovations to the marketplace for the benefit of cancer patients, and provide Dartmouth students with learning opportunities in biomedical entrepreneurship.
A newly awarded $820,000 grant from The National Cancer Institute will allow a team of multi-disciplinary investigators to increase clinical trial awareness and participation for rural patients who make up almost half of the area served by Dartmouth’s and Dartmouth-Hitchcock’s Norris Cotton Cancer Center.
A new study uncovers how the most commonly mutated tumor suppressor gene in cancer and the most commonly mutated oncogene in cancer cooperate to drive formation of pancreatic cancer.
A $328,000 National Cancer Institute (NCI) grant will enable researchers at Dartmouth’s and Dartmouth-Hitchcock’s Norris Cotton Cancer Center (NCCC) to investigate one of the mechanisms that may be responsible for the body’s inability to fight COVID-19.